Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in cynomolgus monkeys

American Journal of Transplantation

Volumn 8, Issue 8, 2008, Pages 1662-1672

  Smith, R N ^a   Kawai, T ^a   Boskovic, S ^a   Nadazdin, O ^a   Sachs, D H ^a   Cosimi, A B ^a   Colvin, R B ^a  

^a NONE

Author keywords

Allograft; Antibody; Chronic; Kidney; Monkey; Rejection

Indexed keywords

ALLOANTIBODY; COMPLEMENT COMPONENT C4D;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DISEASE; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; ENDARTERITIS; GRAFT SURVIVAL; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; MONKEY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CHRONIC DISEASE; GRAFT REJECTION; GRAFT SURVIVAL; HAPLORHINI; ISOANTIBODIES; KIDNEY TRANSPLANTATION; TRANSPLANTATION TOLERANCE;

EID: 48349092133     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02303.x     Document Type: Article

References (91)

1. Feucht HE, Felber E, Gokel MJ et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 1991 86 : 464 470.
2. Feucht HE, Schneeberger H, Hillebrand G et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993 43 : 1333 1338.
3. Collins AB, Schneeberger EE, Pascual MA et al. Complement activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999 10 : 2208 2214.
4. Mauiyyedi S, Colvin RB. Humoral rejection in kidney transplantation: New concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens 2002 11 : 609 618.
5. Mauiyyedi S, Crespo M, Collins AB et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002 13 : 779 787.
6. Mauiyyedi S, Pelle PD, Saidman S et al. Chronic humoral rejection: Identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001 12 : 574 582.
7. Crespo M, Pascual M, Tolkoff-Rubin N et al. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation 2001 71 : 652 658.
8. Bohmig GA, Exner M, Habicht A et al. Capillary C4d deposition in kidney allografts: A specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 2002 13 : 1091 1099.
9. Haas M, Ratner LE, Montgomery RA. C4d staining of perioperative renal transplant biopsies. Transplantation 2002 74 : 711 717.
10. Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ. Detection of the complement degradation product C4d in renal allografts: Diagnostic and therapeutic implications. J Am Soc Nephrol 2002 13 : 242 251.
11. Koo DD, Roberts IS, Quiroga I et al. C4d deposition in early renal allograft protocol biopsies. Transplantation 2004 78 : 398 403.
12. Sijpkens YW, Joosten SA, Wong MC et al. Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney Int 2004 65 : 2409 2418.
13. Herman J, Lerut E, Van Damme-Lombaerts R, Emonds MP, Van Damme B. Capillary deposition of complement C4d and C3d in pediatric renal allograft biopsies. Transplantation 2005 79 : 1435 1440.
14. Scornik JC, Guerra G, Schold JD, Srinivas TR, Dragun D, Meier-Kriesche HU. Value of posttransplant antibody tests in the evaluation of patients with renal graft dysfunction. Am J Transplant 2007 7 : 1808 1814.
15. Worthington JE, McEwen A, McWilliam LJ, Picton ML, Martin S. Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome. Transplantation 2007 83 : 398 403.
16. Horita S, Nitta K, Kawashima M et al. C4d deposition in the glomeruli and peritubular capillaries associated with transplant glomerulopathy. Clin Transplant 2003 17 : 325 330.
17. Cardarelli F, Pascual M, Tolkoff-Rubin N et al. Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation. Transpl Int 2005 18 : 532 540.
18. Vongwiwatana A, Gourishankar S, Campbell PM, Solez K, Halloran PF. Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. Am J Transplant 2004 4 : 124 129.
19. Sijpkens YW, Doxiadis, II, van Kemenade FJ et al. Chronic rejection with or without transplant vasculopathy. Clin Transplant 2003 17 : 163 170.
20. Regele H, Bohmig GA, Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002 13 : 2371 2380.
21. Mengel M, Bogers J, Bosmans JL et al. Incidence of C4d stain in protocol biopsies from renal allografts: Results from a multicenter trial. Am J Transplant 2005 5 : 1050 1056.
22. Haas M, Montgomery RA, Segev DL et al. Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts. Am J Transplant 2007 7 : 576 585.
23. Mengel M, Bogers JP, Bosmans JL, Seron D, Gwinner W, Haller H. Incidence of C4d staining and morphology of acute humoral rejection in protocol biopsies of renal allografts: A multicenter study. J Am Soc Nephrol 2003 14 : 11A.
24. Nickerson P, Gibson IW, Karpinski M et al. C4d deposition in protocol biopsies from flow cytometry crossmatch positive or negative renal transplant recipients. J Am Soc Nephrol 2002 13 : 567A.
25. Takemoto SK, Zeevi A, Feng S et al. A national conference to assess antibody mediated rejection in solid organ transplantation. A J Transplant 2004 4 : 1033 1041.
26. Colvin RB, Smith RN. Antibody-mediated organ allograft rejection. Nat Rev Immunol 2005 5 : 807 817.
27. Kawai T, Cosimi AB, Colvin RB et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995 59 : 256 262.
28. Kimikawa M, Sachs DH, Colvin RB, Bartholomew A, Kawai T, Cosimi AB. Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys. Transplantation 1997 64 : 709 716.
29. Kawai T, Poncelet A, Sachs DH et al. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation 1999 68 : 1767 1775.
30. Kawai T, Wee SL, Bazin H et al. Association of natural killer cell depletion with induction of mixed chimerism and allograft tolerance in non-human primates. Transplantation 2000 70 : 368 374.
31. Abe M, Kawai T, Futatsuyama K et al. Postoperative production of anti-donor antibody and chronic rejection in renal transplantation. Transplantation 1997 63 : 1616 1619.
32. Boskovic S, Kawai T, Smith RN et al. Monitoring antidonor alloantibodies as a predictive assay for renal allograft tolerance/long-term observations in nonhuman primates. Transplantation 2006 82 : 819 825.
33. Smith RN, Kawai T, Boskovic S et al. Chronic antibody mediated rejection of renal allografts: Pathological, serological and immunologic features in nonhuman primates. Am J Transplant 2006 6 : 1790 1798.
34. Kawai T, Abrahamian G, Sogawa H et al. Costimulatory blockade for induction of mixed chimerism and renal allograft tolerance in nonhuman primates. Transplant Proc 2001 33 : 221 222.
35. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003 3 : 708 714.
36. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999 55 : 713 723.
37. Wavamunno MD, O'Connell PJ, Vitalone M et al. Transplant glomerulopathy: Ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am J Transplant 2007 7 : 2757 2768.
38. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003 3 : 665 673.
39. Lee PC, Terasaki PI, Takemoto SK et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002 74 : 1192 1194.
40. Worthington JE, Martin S, Al-Husseini DM, Dyer PA, Johnson RW. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplantation 2003 75 : 1034 1040.
41. Platt JL. C4d and the fate of organ allografts. J Am Soc Nephrol 2002 13 : 2417 2419.
42. Torrealba JR, Fernandez LA, Kanmaz T et al. Immunotoxin-treated rhesus monkeys: A model for renal allograft chronic rejection. Transplantation 2003 76 : 524 530.
43. Wieczorek G, Bigaud M, Menninger K et al. Acute and chronic vascular rejection in nonhuman primate kidney transplantation. Am J Transplant 2006 6 : 1285 1296.
44. Feucht HE. Complement C4d in graft capillaries - the missing link in the recognition of humoral alloreactivity. Am J Transplant 2003 3 : 646 652.
45. Abe M, Sawada T, Horita S, Toma H, Yamaguchi Y, Teraoka S. C4d deposition in peritubular capillary and alloantibody in the allografted kidney suffering severe acute rejection. Clin Transplant 2003 17 (Suppl 10 14 19.
46. Kato M, Morozumi K, Takeuchi O et al. Complement fragment C4d deposition in peritubular capillaries in acute humoral rejection after ABO blood group-incompatible human kidney transplantation. Transplantation 2003 75 : 663 665.
47. Perrey C, Brenchley PE, Johnson RW, Martin S. An association between antibodies specific for endothelial cells and renal transplant failure. Transpl Immunol 1998 6 : 101 106.
48. Martin S, Brenchley PE, Postlethwaite RJ, Johnson RW, Dyer PA. Detection of anti-epithelial cell antibodies in association with pediatric renal transplant failure using a novel microcytotoxicity assay. Tissue Antigens 1991 37 : 152 155.
49. Wu GD, Jin YS, Salazar R et al. Vascular endothelial cell apoptosis induced by anti-donor non-MHC antibodies: A possible injury pathway contributing to chronic allograft rejection. J Heart Lung Transplant 2002 21 : 1174 1187.
50. Martin L, Guignier F, Mousson C, Rageot D, Justrabo E, Rifle G. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy. Transplantation 2003 76 : 395 400.
51. Cornell LD, Della Pelle P, Brousiadies N, Collins AB, Colvin RB. Endothelial response to rejection: Enhanced expression of complement regulatory proteins decay accelerating factor (DAF, CD55) and protectin (CD59) in human renal allografts. Mod Pathol 2004 17 (Suppl 1 285A.
52. Otterbein LE, Zuckerbraun BS, Haga M et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 2003 9 : 183 190.
53. Soares MP, Lin Y, Sato K, Stuhlmeier KM, Bach FH. Accommodation. Immunol Today 1999 20 : 434 437.
54. Sund S, Hovig T, Reisaeter AV, Scott H, Bentdal O, Mollnes TE. Complement activation in early protocol kidney graft biopsies after living-donor transplantation. Transplantation 2003 75 : 1204 1213.
55. Akalin E, Dinavahi R, Dikman S et al. Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining. Clin J Am Soc Nephrol 2007 2 : 1261 1267.
56. Gloor JM, Sethi S, Stegall MD et al. Transplant glomerulopathy: Subclinical incidence and association with alloantibody. Am J Transplant 2007 7 : 2124 2132.
57. Namba Y, Oka K, Moriyama T et al. Incidence of positive C4d deposition in long-term survival cases over 10 yr after renal transplantation. Clin Transplant 2006 20 (Suppl 15 20 25.
58. Sis B, Campbell PM, Mueller T et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007 7 : 1743 1752.
59. Regele H, Exner M, Watschinger B et al. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant 2001 16 : 2058 2066.
60. Magil AB, Tinckam K. Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection. Kidney Int 2003 63 : 1888 1893.
61. Kuypers DR, Chapman JR, O'Connell PJ, Allen RD, Nankivell BJ. Predictors of renal transplant histology at three months. Transplantation 1999 67 : 1222 1230.
62. Colvin RB, Cohen AH, Saiontz C et al. Evaluation of pathologic criteria for acute renal allograft rejection: Reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol 1997 8 : 1930 1941.
63. Nickeleit V, Vamvakas EC, Pascual M, Poletti BJ, Colvin RB. The prognostic significance of specific arterial lesions in acute renal allograft rejection. J Am Soc Nephrol 1998 9 : 1301 1308.
64. Heeger PS, Lalli PN, Lin F et al. Decay-accelerating factor modulates induction of T cell immunity. J Exp Med 2005 201 : 1523 1530.
65. Baldwin WM, Ota H, Rodriguez ER. Complement in transplant rejection: Diagnostic and mechanistic considerations. Springer Semin Immunopathol 2003 25 : 181 197.
66. Rahimi S, Qian Z, Layton J, Fox-Talbot K, Baldwin WM 3rd., Wasowska BA. Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. Am J Transplant 2004 4 : 326 334.
67. Uehara S, Chase CM, Kitchens WH et al. NK cells can trigger allograft vasculopathy: The role of hybrid resistance in solid organ allografts. J Immunol 2005 175 : 3424 3430.
68. Kondadasula SV, Roda JM, Parihar R et al. Co-localization of the IL-12 receptor and Fc{gamma}RIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-{gamma}. Blood 2008 111 : 4173 4183.
69. Bian H, Reed EF. Anti-HLA class I antibodies transduce signals in endothelial cells resulting in FGF receptor translocation, down-regulation of ICAM-1 and cell proliferation. Transplant Proc 2001 33 : 311.
70. Benzaquen LR, Nicholson-Weller A, Halperin JA. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J Exp Med 1994 179 : 985 992.
71. Jin YP, Singh RP, Du ZY, Rajasekaran AK, Rozengurt E, Reed EF. Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner. J Immunol 2002 168 : 5415 5423.
72. Gong KW, Jin YP, Lepin EJ, Chen HW, Lee H, Reed EF. Class I mediated signal transduction in smooth muscle cells. Hum Immunol 2003 64 (10 Suppl S60.
73. Lin Y, Soares MP, Sato K et al. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts. J Immunol 1999 163 : 2850 2857.
74. Suhr BD, Black SM, Guzman-Paz M, Matas AJ, Dalmasso AP. Inhibition of the membrane attack complex of complement for induction of accommodation in the hamster-to-rat heart transplant model. Xenotransplantation 2007 14 : 572 579.
75. Wang H, Arp J, Liu W et al. Inhibition of terminal complement components in presensitized transplant recipients prevents antibody-mediated rejection leading to long-term graft survival and accommodation. J Immunol 2007 179 : 4451 4463.
76. Ding JW, Zhou T, Ma L et al. Expression of complement regulatory proteins in accommodated xenografts induced by anti-alpha-Gal IgG in a rat-to-mouse model. Am J Transplant 2008 8 : 32 40.
77. Heslan JM, Renaudin K, Thebault P, Josien R, Cuturi MC, Chiffoleau E. New evidence for a role of allograft accommodation in long-term tolerance. Transplantation 2006 82 : 1185 1193.
78. Lin Y, Soares MP, Sato K et al. Long-term survival of hamster hearts in presensitized rats. J Immunol 2000 164 : 4883 4892.
79. Cecka JM, Zhang Q, Reed EF. Preformed cytotoxic antibodies in potential allograft recipients: Recent data. Hum Immunol 2005 66 : 343 349.
80. Narayanan K, Jendrisak MD, Phelan DL, Mohanakumar T. HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway. Transpl Immunol 2006 15 : 187 197.
81. Shimizu I, Smith NR, Zhao G, Medof E, Sykes M. Decay-accelerating factor prevents acute humoral rejection induced by low levels of anti-alphaGal natural antibodies. Transplantation 2006 81 : 95 100.
82. King KE, Warren DS, Samaniego-Picota M, Campbell-Lee S, Montgomery RA, Baldwin WM 3rd. Antibody, complement and accommodation in ABO-incompatible transplants. Curr Opin Immunol 2004 16 : 545 549.
83. Segev DL, Simpkins CE, Warren DS et al. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 2005 5 : 2570 2575.
84. Takahashi K. Recent findings in ABO-incompatible kidney transplantation: Classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-blood-group-related antigens during the critical period preceding the establishment of accommodation. Clin Exp Nephrol 2007 11 : 128 141.
85. Kirk AD, Burkly LC, Batty DS et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999 5 : 686 693.
86. Kirk AD, Harlan DM, Armstrong NN et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 1997 94 : 8789 8794.
87. Auchincloss H, Jr., Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci USA 1993 90 : 3373 3377.
88. Gould DS, Auchincloss H Jr. Direct and indirect recognition: The role of MHC antigens in graft rejection. Immunol Today 1999 20 : 77 82.
89. Steele DJ, Laufer TM, Smiley ST et al. Two levels of help for B cell alloantibody production. J Exp Med 1996 183 : 699 703.
90. Kirk AD, Baldwin WM, Cascalho MI, Chong AS, Sykes M, West LJ. American society of transplantation symposium on B cells in transplantation: Harnessing humoral immunity from rodent models to clinical practice. Am J Transplant 2007 7 : 1464 1470.
91. Pollinger HS, Stegall MD, Gloor JM et al. Kidney transplantation in patients with antibodies against donor HLA class II. Am J Transplant 2007 7 : 857 863.